Assessment of disease progression in the zQ175 Heterozygous Huntington’s mouse model

Author:Florian Schmid  Graham Ruby  Johannes Riegler  

Session Type:Digital Poster  

Session Date:Wednesday, 08 May 2024  

Session Name:Preclinical Neuroimaging: Axons, Myelin & Disease Models  

Program Number:4115  

Room Session:Exhibition Hall (Hall 403)  

Institution:Calico Life Sciences  

Characterization of atlas based volumetric changes in unilateral 6-OHDA-induced Parkinson’s rat model

Delayed CSF clearance may provide a more sensitive disease marker than blood-CSF-barrier impairment in an Alzheimer’s disease mouse model

Diffusion Tensor Imaging Along the Perivascular Space Index in Idiopathic Intracranial Hypertension

Discrepancy in the distribution of H217O and Gd-DTPA during and after intrathecal infusion in chronic unilateral hypoperfusion model mice.

DTI and NODDI to monitor treatment effect for stroke in middle cerebral artery occlusion mouse model

Histological validation of Quantitative Gradient Recalled Echo (qGRE) MRI as in vivo early neurodegeneration biomarker in Alzheimer’s Disease

The impact of high-fat, obesogenic diets on brain volume in a commercially available mouse model of fatty liver disease.

Modeling Behavior, Functional Connectomics, and Proteomics in a Mouse Model of Alzheimer’s Disease

Modeling structural and functional connectomics with proteomics in a preclinical model of tauopathy

Predicting Pain caused by the Intervertebral Disc Degeneration in Large Animal Model Using CEST MRI Data

Progressive brain volume alterations in the zQ175DN mouse model of Huntington’s Disease using in vivo MRI